Handelsavisen
prelaunch
Companies Healthcare 3649.T
36
3649.T Tokyo Stock Exchange Advanced Medical Equipment & Technology

Findex Inc

¥784,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
19,1B JPY
P/E
14,8x
EV / Rev
2,6x
Div yield
2,79 %
Op margin
40,6 %
ROE
12,2 %
Net margin
30,3 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Findex Inc is a Japanese company specializing in healthcare equipment, providing diagnostic and monitoring solutions for medical institutions.

Business. Findex Inc is a healthcare company specializing in advanced medical equipment and technology, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange under the ticker symbol 3649.T. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
14,8x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 3649.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 3649.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Findex Inc is a healthcare company specializing in advanced medical equipment and technology, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange under the ticker symbol 3649.T. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Findex Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥2.896 billion, representing 44.2% of total assets. The company operates with no long-term debt, resulting in a debt-to-equity ratio of 0.0 and a current ratio of 5.94, indicating robust short-term financial health. The price-to-book ratio of 3.53 and price-to-tangible-book ratio of 3.53 suggest that the market values the company at a premium to its book value.

    In terms of profitability, Findex Inc reports a return on equity (ROE) of 12.23% and a return on assets (ROA) of 9.83%, both exceeding the typical thresholds for the healthcare equipment industry. The company's operating margin of 40.6% (calculated from operating income of ¥862.1 million on revenue of ¥2.125 billion) is significantly higher than the industry median, indicating efficient cost management and strong pricing power.

    Geographically, Findex Inc's revenue is primarily concentrated in Japan, with no disclosed international segments. The company's business is not diversified across multiple product lines, as it focuses on healthcare equipment, particularly diagnostic and monitoring solutions. This concentration may expose the company to regional economic and regulatory risks, though no immediate geopolitical threats are flagged in the industry configuration.

    Looking ahead, Findex Inc is projected to grow revenue by approximately 23.6% in the next fiscal year, based on analyst estimates of ¥6.25 billion compared to the last actual revenue of ¥6.11 billion. The company's earnings per share (EPS) are also expected to increase, with a mean estimate of ¥54.10 compared to the last actual EPS of ¥50.07. This growth trajectory is supported by the company's strong cash position and lack of debt, which allows for reinvestment and potential expansion.

    The risk assessment for Findex Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's dilution potential is also low, as there is no indication of recent or planned share issuances that could dilute existing shareholders. The absence of long-term debt and the high current ratio further mitigate financial risk.

    Recent events and filings for Findex Inc do not highlight any significant operational or financial disruptions. The company's latest financial results and analyst estimates suggest stable performance and positive expectations for the near term. No major regulatory changes or market shifts have been reported that would significantly impact the company's operations or valuation.

    Key takeaways
    • Findex Inc has a strong liquidity position with no long-term debt and a current ratio of 5.94.
    • The company's profitability metrics, including ROE of 12.23% and ROA of 9.83%, are above industry norms.
    • Revenue is concentrated in Japan, with no disclosed international segments, which may pose regional risk.
    • Analysts expect a 23.6% revenue growth in the next fiscal year, supported by strong cash reserves.
    • The company faces low liquidity and dilution risks, with no immediate filing-based flags detected.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Operating income surged 13.8% year-over-year to JPY 1.73 billion, demonstrating strong top-line momentum and operational efficiency.

    The company maintains a zero long-term debt position, eliminating interest expense risks and providing maximum financial flexibility.

    Free cash flow grew 19.1% year-over-year to JPY 880.8 million, highlighting robust cash generation capabilities.

    BEAR CASE · 3

    Revenue growth decelerated to 4.6% year-over-year in FY2026, suggesting potential saturation or slowing demand in core markets.

    Operating income growth slowed to 13.8% in FY2026 compared to higher historical rates, indicating margin expansion challenges.

    Net income growth of 8.1% lags behind the 18.6% four-year CAGR, signaling a potential normalization of earnings power.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-12
    Q4 2025 · Quarter highlights

    Revenue ¥1.74B, +13,4% YoY; Operating income +35,3% YoY.

    Revenue¥1.74B+13,4 % YoY
    Operating income¥538.2M+35,3 % YoY
    Net income¥403.5M+22,0 % YoY
    Free cash flow
    EPS
    Operating cash flow¥1.65B−13,0 % YoY
    Financials
    Income statement
    Revenue¥1.74B
    Gross profit¥1.17B
    Operating income¥538.2M
    Net income¥403.5M
    Margins
    Gross margin67.5%
    Operating margin31.0%
    Net margin23.2%
    FCF margin
    Balance sheet
    Total assets¥6.81B
    Total liabilities¥1.37B
    Total equity¥5.44B
    Cash & equivalents¥1.68B
    Long-term debt¥0.00
    Cash flow
    Operating cash flow¥1.65B
    CapEx-¥296.7M
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue ¥1.74BOperating costs ¥1.20BTax ¥134.7MNet income ¥403.5M
    Highlights
    • Revenue ¥1.74B, +13,4% YoY
    • Operating income +35,3% YoY
    • Net income +22,0% YoY
    • Net margin 23.2%

    Valuation TTM

    Market price
    ¥784,00
    Market cap
    ¥18.56B
    Enterprise value
    ¥15.67B
    P/E
    14.8x
    Non-GAAP P/E
    EV / Revenue
    2.6x
    EV / Op income
    9.0x
    EV / OCF
    P / B
    3.5x
    P / Tangible book
    3.5x
    Tangible book
    ¥5.26B
    Net cash
    ¥2.90B
    Current ratio
    5.9
    Debt / equity
    0.0
    ROA
    9.8%
    ROE
    12.2%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    54,10
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-11 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate54,10
    Revenueno estimateno estimate6,2B JPY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in JPY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data
    EPS surprise
    −7,5 %
    reported vs consensus · miss
    Revenue surprise
    −2,2 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin40,6 %Above P75
    Net Margin30,3 %Above P75
    ROE12,2 %Above P75
    D/E0,00Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Findex Inc Market data — financials · 2026-05-26
    • Findex Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    3649.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-02-12 08:59 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 1.74B · Net JPY 403.5M
    2026-02-12 08:59 UTCEARNINGSAnnual results — FY 2026 Revenue JPY 6.11B · Net JPY 1.26B
    2025-11-13 08:04 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 1.25B · Net JPY 167.8M
    2025-08-13 12:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 1.17B · Net JPY 107.4M
    2025-05-14 12:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 1.95B · Net JPY 578.3M
    2025-02-13 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 1.53B · Net JPY 330.7M
    2025-02-13 12:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 5.84B · Net JPY 1.16B
    2024-11-13 12:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 1.10B · Net JPY 130.3M
    2024-08-13 12:00 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 1.08B · Net JPY 58.4M
    2024-05-14 12:26 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 2.12B · Net JPY 642.9M
    2024-02-13 12:00 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 5.19B · Net JPY 1.06B
    2023-02-13 12:02 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 4.54B · Net JPY 722.8M
    2022-02-09 12:00 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 4.97B · Net JPY 636.0M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage